2018
Antenatal depression, psychotropic medication use, and inflammation among pregnant women
Miller E, Grobman W, Culhane J, Adam E, Buss C, Entringer S, Miller G, Wadhwa P, Keenan-Devlin L, Borders A. Antenatal depression, psychotropic medication use, and inflammation among pregnant women. Archives Of Women's Mental Health 2018, 21: 785-790. PMID: 29862416, PMCID: PMC6240365, DOI: 10.1007/s00737-018-0855-9.Peer-Reviewed Original ResearchConceptsAntenatal depressive symptomsInflammatory biomarkersPregnant womenProspective multicenter observational studyCross-sectional secondary analysisContext of pharmacotherapyHigher TNFα levelsMulticenter observational studyEpidemiologic Studies Depression ScalePsychotropic medication useLower TNFαPre-existing high levelsAntenatal depressionMedication useSerum TNFαTNFα levelsWeeks' gestationSelf-reported useDepression screenPsychotropic medicationsTNFα concentrationsMedical recordsPoor responseTherapeutic responseObservational study
2004
Maternal Depressive Symptoms and Infant Health Practices Among Low-Income Women
Chung E, McCollum K, Elo I, Lee H, Culhane J. Maternal Depressive Symptoms and Infant Health Practices Among Low-Income Women. Pediatrics 2004, 113: e523-e529. PMID: 15173532, DOI: 10.1542/peds.113.6.e523.Peer-Reviewed Original ResearchConceptsMaternal depressive symptomsBack sleep positionInjury prevention measuresDepressive symptomsSleep positionTime pointsInfant health service useEpidemiologic Studies Depression ScalePersistent depressive symptomsHealth service usePublic Health CenterInfant health servicesWell-child carePercent of womenCommunity-based surveyAfrican American womenInfant receiptPersistent symptomsInfant hospitalizationMean ageSmoke alarmsPostpartum periodHealth centersDepression ScaleService use